Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 1,950 shares at $23.16 ($45K) on 2024-06-18, disclosed to the SEC on 2024-06-18.
Scheduled sale ($45k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |